M.D. Alert Published: March 5, 2021 Read the Full Commentary >> (Reuters Health) – Women have better screening outcomes with digital breast tomosynthesis, but a new study suggests that Black women have less access to this imaging modality. Researchers examined data on 385,503 women screened at one of 63 U.S. breast imaging facilities between 2015[…]
Journal of the American College of Radiology Published: February 16, 2021 Read the Full Manuscript >> Abstract Purpose Digital breast tomosynthesis (DBT) in conjunction with digital mammography (DM) is becoming the preferred imaging modality for breast cancer screening compared with DM alone, on the basis of improved recall rates (RR) and cancer detection rates (CDRs).[…]
Thu, Mar 18, 2021 11:30 AM – 12:30 PM EDT Register Automated data networks are transforming prospective research by adding value in ways not possible with traditional registries. This webinar challenges the status quo and explores innovative approaches to building and leveraging data networks for succeeding in the new world of real-world data and multi-stakeholder[…]
BOSTON, Feb. 18, 2021 /PRNewswire/ — OM1, a leading real-world data (RWD), health outcomes and technology company, today announced the publication of clinical trial results in JAMA Network Open demonstrating its tool, OM1™ Joint Insights, positively impacts decision quality, shared decision making, patient experience, and functional outcomes in adults with knee osteoarthritis (OA). In the U.S., more than 30 million adults[…]
Thu, Feb 25, 2021 11:00 AM – 12:00 PM EST Register Accessibility to real-world data (RWD) and advances in artificial intelligence (AI) driven models and technologies make a powerful combination in advancing research and development efforts. So how do we use these new tools to tackle the challenges in developing and launching new treatments for[…]
